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The cytochromes P450 (P450s) are a superfamily of hemoproteins that catalyze oxidative biotransformation of numerous xenobiotics including drugs, carcinogens, and organic solvents. Mechanism-based inactivation of P450s often occurs when reactive intermediates generated by the P450-catalyzed reactions covalently modify the heme or critical amino acid residues. Inactivation of P450 catalysis can have significant ramifications on the pharmacokinetics of pharmaceutical drugs and other xenobiotics as it is often associated with adverse drug-drug interactions and toxicity . It is therefore important to understand the mechanism of P450 catalysis in order to minimize the adverse effect.
All P450s contain a protoporphyrin IX prosthetic cofactor ligated to a cysteinyl residue. Through sequential addition of two electrons from cytochrome P450 reductase (CPR), the P450s activate the dioxygen molecule, split the O-O bond and subsequently insert one oxygen atom into their substrates (for details, see Denisov et al., 2005; Hamdane et al., 2008) Classic examples of mechanism-based inactivators of P450s are acetylenic compounds. Many aliphatic and arylacetylenes have been reported by our group and others to be mechanism-based inactivators of various isoforms of P450s Komives and Ortiz de Montellano, 1987; Ortiz de Montellano and Kunze, 1980; Wright et al., 2009) . For example, 17α-This article has not been copyedited and formatted. The final version may differ from this version. , respectively (Kent et al., 2006) . Both tert-butylacetylene (tBA) and tert-butyl-1-methyl-2-propynl ether (tBMP) inactivate P450 2E1
predominantly through the formation of heme adducts. A novel reversible formation of a tBA-heme adduct was observed for the T303A variant of P450 2E1 (Blobaum et al., 2005) . Earlier work reported that phenylacetylenes inactivate P450 2B1 through heme alkylation whereas 1-ethynylpyrene inactivated P450
1A1 by protein alkylation (Chan et al., 1993; Gan et al., 1984; Komives and Ortiz de Montellano, 1987; Ortiz de Montellano and Komives, 1985) . Other acetylenic mechanism-based inactivators of P450s include 5-phenyl-1-pentyne (Roberts et al., 1998) , 2-ethynylnaphthalene (Roberts et al., 1994) , 9-ethynylphenathrene (Roberts et al., 1995) , 7-ethynylcoumarin (Kent et al., 2001) , to name a few.
Even though many acetylenic compounds have been identified as mechanismbased inactivators of P450s, the effects of protein alkylation by these acetylenic compounds on the catalytic mechanism have not yet been characterized in detail.
This is in part due to low k inact and high partition ratio for many mechanism-based inactivators. These factors contribute to the difficulty in obtaining homogenously modified P450s for further mechanistic studies.
In this study, we report that tBPA is a potent mechanism-based inactivator of P450 2B4 with a partition ratio of close to zero. tBPA inactivates P450 2B4 by forming a single covalent adduct with the Thr302 with a stoichiometry for inactivation of 1:1 without modification or loss of the heme. Furthermore, the Over-expression and purification of P450 2B4, NADPH-dependent cytochrome P450 reductase, and cytochrome b5. The plasmid for overexpression of P450 2B4 (pKK2B4dH) was a generous gift from Dr. James
Halpert (University of California at San Diego, CA). P450 2B4 was expressed as a truncated form where the hydrophobic membrane-spanning domain had been removed (Δ3-21) and several positively charged residues introduced into the Nterminus to increase the expression yield. This truncated P450 2B4 was overexpressed in Escherichia coli C41(DE3) cells and purified with a Ni-affinity followed by a CM-sepharose cation exchange column as described by Halpert and co-workers (Scott et al., 2001) . NADPH-dependent cytochrome P450 reductase (CPR) and cytochrome b5 (cyt b5) were over-expressed and purified as previously described (Zhang et al., 2009 ).
This article has not been copyedited and formatted. The final version may differ from this version. were transferred to a secondary reaction mixture that contained 0.1 mM 7-EFC and 0.3 mM NADPH in 50 mM potassium phosphate (pH 7.4). The secondary reactions were terminated after incubation for 10 min by the addition of 50 μL of ice-cold acetonitrile. The fluorescent intensity of the 7-hydroxy-4-trifluoromethylcoumarin (7-HFC) product was measured at 520 nm with excitation at 410 nm and used to calculate the activity remaining of the P450 2B4. The results were expressed as percentage of the control sample from which tBPA was omitted.
Partition ratio for the mechanism-based inactivation of P450 2B4 by tertbutylphenyl acetylene. To determine the partition ratio, the primary reaction mixture containing P450 2B4, CPR, cyt b5 (when present), catalase, and various concentrations of tBPA as indicated was incubated as previously described except that incubation of the primary reaction mixture was allowed to proceed for 30 min at 30 o C until the mechanism-based inactivation was complete. The activity remaining after the inactivation of P450 2B4 was analyzed using the This article has not been copyedited and formatted. The final version may differ from this version. secondary reaction mixture as described above. The partition ratio was then determined as previously described (Kent et al., 1997) .
Analyses of the tBPA-modified P450 2B4 protein by ESI-LC/MS. The tBPAmodified P450 protein was analyzed by ESI-LC/MS using a LCQ ion-trap mass spectrometer (ThermoScientific, Waltham, MA) as previously described (Zhang et al., 2009) . Following incubation with tBPA and NADPH for the times indicated, an aliquot (50 μL) of the primary reaction solution was applied to a reverse-phase 2B4 was then purified to homogeneity from the reaction mixture using a Niaffinity column followed by cation-exchange chromatography as described previously (Scott et al., 2001 ). The purified tBPA-modified P450 2B4 was then The LC-MS/MS datasets for the tryptic digests of the tBPA-modified P450
2B4 were exported to the Bioworks program (ver. 3.3.1) and the modified amino acid residues were identified using the SEQUEST database search function of the Bioworks program. To reduce false hits, the cross-correlation score (XCorr) measuring the quality of the match between experimental data and the predicted fragment patterns was set at 2.0, 2.5, and 3.6 for singly, doubly and triply charged ions, respectively. Only those hits from the SEQUEST database search that had a possibility score less than 1×10 -3 were considered. Catalytic activity of the tBPA-modified P450 2B4 under steady-state conditions. The relative turnover rates for the metabolism of 7-EFC, benzphetamine and testosterone by the tBPA-modified P450 2B4 were determined under steady-state conditions as previously described (Zhang et al., 2009 ). To determine the effect of the covalently bound tBPA, the turnover rates for both the tBPA-modified and unmodified P450s were measured under identical conditions.
Rates of reduction of unmodified
This article has not been copyedited and formatted. The final version may differ from this version. . In the presence of one equivalent of cyt b5, which is known to stimulate the activity of some P450s, both the K I and k inact are increased to 0.73 μM and 0.25 min -1 respectively. The overall inactivation efficiency (k inact /K I ) is not significantly affected by cyt b5, but cyt b5 seems to accelerate the rate of the mechanism-based inactivation by twofold. Based on this observation, cyt b5 was included in the primary reaction mixture to prepare the tBPA-modified P450 2B4.
Partition ratio for the mechanism-based inactivation of P450 2B4 by tertbutylphenylacetylene. The partition ratio for the mechanism-based inactivation of P450 2B4 by tBPA was determined in the absence and presence of cyt b5. As shown in Figure 2 , the activity remaining for the inactivated P450 2B4 decreases with increasing molar ratios of tBPA to P450 as expected. The partition ratio was determined to be close to zero. The near zero partition ratio indicates that the reactive intermediate of tBPA inactivates P450 2B4 without leaving the active site (Silverman, 1995) . The residual activity of the inactivated P450 2B4 is approximately 22% of the control sample in the absence of cyt b5.
This article has not been copyedited and formatted. The final version may differ from this version. Figure 3 . The P450 2B4 sample obtained after 5 min of incubation with NADPH yielded two mass peaks at 53948 and 54122 Da (Fig. 3A) . (Fig. 3C ). These results demonstrate that the mechanism-based inactivation of P450 2B4 by tBPA leads to the formation of tBPA-protein adduct with a 1:1 stoichiometry. No loss in the heme content was observed by HPLC analyses of the tBPA-modified P450 2B4 (data not shown).
The ability to make fully tBPA-labeled P450 2B4 provides a unique opportunity to study the mechanism(s) by which the covalently bound tBPA affects P450
catalysis.
Optical absorption spectra of the tBPA-modified P450 2B4. The optical absorption spectrum of the tBPA-modified P450 2B4 is shown in Figure 4 in perturbed. Thus, it is reasonable to suggest that the site of covalent modification of the P450 by tBPA is located in proximity to the heme. In marked contrast to the results with the unmodified P450 2B4, the addition of benzphetamine to the tBPA-modified P450 2B4 does not result in any significant spectral changes (Fig.   4 ). The spectrum of the tBPA-modified P450 2B4 in the presence of 1 mM benzphetamine is virtually identical to that observed in the absence of 1 mM benzphetamine. In this case, the lack of a type I spectral change suggests that
This article has not been copyedited and formatted. The final version may differ from this version. Effect of the covalently bound tBPA on the catalytic activity of P450 2B4.
The impact of the covalently bound tBPA on the catalytic activity was evaluated by determining the relative turnover rates of the tBPA-modified protein for 7-EFC, benzphetamine, and testosterone under steady-state conditions. Like the unmodified P450 2B4, the tBPA-modified P450 2B4 metabolizes testosterone to
give three major metabolites as reported by Hernandez et al. (2006) . The amounts of all three metabolites were added together to calculate the relative overall turnover rate. The results show that the tBPA-modified P450 2B4
catalyzes the oxidation of 7-EFC, benzphetamine, and testosterone at 30, 21, and 9.6% of the rates for the unmodified P450 2B4, respectively. It is clear that the covalent modification by tBPA impairs the catalytic activity of P450 2B4, but the extent of the impaired activity varies with the nature of substrates.
Effect of the covalent modification of P450 2B4 by tBPA on the rate of electron transfer from P450 reductase to ferric P450 2B4. To investigate the mechanisms of the impaired catalytic activity, we measured the rate of electron transfer from CPR to the ferric P450 2B4, referred to as the first electron transfer.
The kinetic traces for the first electron transfer to the unmodified P450 2B4 are shown in Figure 5 , together with those for the tBPA-modified P450 2B4. In the absence of 1 mM benzphetamine, the kinetic trace for the unmodified P450 2B4
is biphasic and can be fit best with double exponentials to give the apparent rate constants, k obs , of 0.14 (12%) and 0.007 s -1
(88%). The numbers in parentheses
This article has not been copyedited and formatted. The final version may differ from this version. This similarity demonstrates that modification of the protein by tBPA does not result in a significant alteration in the rate of electron flow from CPR to the ferric P450 2B4. In contrast, the rate of the first electron transfer to the unmodified P450 2B4 is greatly enhanced in the presence of 1 mM benzphetamine and to much lesser extent for the tBPA-modified P450 2B4. Fitting of the kinetic trace for the reduction of the unmodified P450 2B4 in the presence of benzphetamine gives biphasic rate constants of 2.8 (86%) and 0.27 s -1 (14%). Thus, the k obs for the fast phase is increased by ~20-fold in the presence of benzphetamine. A significant increase in the rate of the first electron transfer in the presence of benzphetamine (~ 10-fold) has previously been reported for the full-length P450
2B4 by other investigators (Imai et al., 1977; Vatsis et al., 1979) . When compared with unmodified P450 2B4, the rate of the first electron transfer for tBPA-modified P450 2B4 is only marginally increased in the presence of 1 mM benzphetamine to give rate constants of 0.48 (22%) and 0.063 (78%). This marginal increase in the rate of electron transfer observed in the presence of benzphetamine is consistent with earlier conclusion that the binding of benzphetamine to the active site of P450 2B4 is impaired in tBPA-modified P450
2B4 (see Fig. 4 ).
Identification of the site for tBPA modification of P450 2B4 by LC-MS/MS.
Peptide mapping was performed to identify the amino acid residue covalently Therefore, molecular modeling provides evidence that helps to explain why Thr302 is the preferred site for covalent modification by tBPA.
This article has not been copyedited and formatted. The final version may differ from this version. 
DISCUSSION
In this study we have demonstrated that tBPA is a potent mechanismbased inactivator of P450 2B4. tBPA inactivates P450 2B4 with a K I of 0.44 μM and a k inact of 0.12 min -1 (Fig. 1) . One outstanding feature for the mechanismbased inactivation of P450 2B4 by tBPA is the very low partition ratio, which is a measure of the ratio of product release to inactivation (Silverman, 1995) . The near zero partition ratio indicates that the reactive intermediate of tBPA
inactivates P450 without leaving the active site. The loss in catalytic activity is due to protein alkylation and not heme alkylation since a single tBPA-protein adduct has been identified by LC-MS analysis (Fig. 3) while HPLC analysis shows no loss in the unmodified heme content (data not shown).
The results of peptide mapping and the lack of evidence for the formation of any modified heme indicate that Thr302 is the primary target for covalent modification and inactivation by tBPA. Our molecular modeling studies shown in Figure 7 support this conclusion and shed light on why Thr302 is the preferred target for modification. It is well documented that acetylenic compounds may inactivate P450s by protein alkylation or heme alkylation (Chan et al., 1993; Ortiz de Montellano and Kunze, 1980; Ortiz de Montellano and Komives, 1985) . Covalent modification of the Thr302 residue in P450 2B4 may have multiple effects on P450 catalysis. Thr302 is thought to be a critical residue for P450 catalysis since it is believed to be involved in proton relay leading to formation of the oxyferryl species (Davydov et al., 1999; Davydov et al., 2001 ).
Mutation of the Thr302 of P450 2B4 to an alanine results in loss of ~85% of the It is unclear whether the tBPA adduct has any influence on the redox potential of the heme. As tBPA is hydrophobic, adduction of tBPA to Thr302 may change the hydrophobicity of the active site and hence modulate the redox potential. However, the lack of any significant change in the rate of the first electron transfer observed in the absence of benzphetamine suggests that any modulation in the redox potential is relatively insignificant with respect to its effect on the electron transfer rate. The substantial increase in the rate of the electron transfer to the unmodified protein in the presence of 1 mM benzphetamine can be attributed to an increase in the redox potential of P450 2B4 as it has been reported that benzphetamine binding to P450 2B4 raises the redox potential by ~85 mV, leading to a ~10-fold increase in the rate of the electron transfer from CPR to the ferric P450 2B4 (Zhang et al., 2003) . This substantial stimulation of the rate of electron transfer is absent for the tBPAmodified P450 2B4. Thus, it can be postulated that benzphetamine is not bound in the active site or if it is bound it is not in the proper orientation inside the active site to raise the redox potential because of the steric hindrance imposed by the tBPA adduct. The active site void of P450 2B4 may not be large enough to allow the binding of a second substrate, in addition to tBPA, so that it is properly positioned for optimal catalysis. It is intriguing that the tBPA-modified P450 2B4
retains partial activities for metabolism of 7-EFC, benzphetamine, and testosterone even though substrate binding to the active site is adversely This article has not been copyedited and formatted. The final version may differ from this version. 24 affected by the tBPA adduct. The residual activities may arise from the conformational flexibility of the P450 structure that allows transient access of the substrates to the active site since it is well documented that the secondary structure of P450 2B4 is very flexible Zhao et al., 2006) .
Further studies are under way to investigate the effect of the tBPA adduct on the formation and stability of the oxygenated intermediates, the proton delivery processes, and the conformational flexibility of the P450 active site.
